Novartis CEO defends call to withhold data from FDA
The chief executive of Novartis on Wednesday defended the company's decision to delay telling the Food and Drug Administration about manipulated data involving its $2.1 million…
The chief executive of Novartis on Wednesday defended the company's decision to delay telling the Food and Drug Administration about manipulated data involving its $2.1 million…